The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate

Scandinavian Journal of Rheumatology

Volumn 28, Issue 3, 1999, Pages 152-156

  Jenkins, E A ^c   Walker Bone, K E ^c   Wood, A ^a   McCrae, F C ^a   Cooper, Cyrus ^b   Cawley, M I D ^c  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Corticosteroid induced osteoporosis; Etidronate; Primary prevention

Indexed keywords

CALCIUM; CORTICOSTEROID; ETIDRONIC ACID; PLACEBO;

ADULT; AGED; ARTICLE; BONE DEMINERALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ALKALINE PHOSPHATASE; ARTHRITIS, RHEUMATOID; CALCIUM; CREATININE; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; ETIDRONIC ACID; FEMALE; FEMUR; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PROSPECTIVE STUDIES; SPINE;

EID: 0033060973     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749950154211     Document Type: Article

References (16)

1. 1. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. NEJM 1983;309:265-8.
2. 2. Hooyman JR, Melton LJ III, Nelson AM, O'Fallon WM, Riggs BL. Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 1984;27:1353-61.
3. 3. Cooper C, Mitchell M, Wickham C. Rheumatoid arthritis, corticosteroid therapy and the risk of hip fracture. Ann Rheum Dis 1995;54:49-52.
4. 4. Hahn TJ. Corticosteroid-induced osteoporosis. Arch Intern Med 1978;138:882-5.
5. 5. Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteoporosis in patients with rheumatic diseases. Ann Rheum Dis 1985;28:361-8.
6. 6. Pearce G, Ryan PFJ, Delmas PD, Tabensky DA, Seeman E. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. BJR 1998;37:292-9.
7. 7. Lukert BP, Johnson BE, Robinson RG. Oestrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 1992;7:1063-9.
8. 8. Reid IR, Ibbertson HK. Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 1986;42:287-90.
9. 9. Hahn TJ, Hahn BH. Osteopenia in patients with rheumatic disease: principles of diagnosis and therapy. Arthritis Rheum 1976;6:165-88.
10. 10. Struys A, Snelder AA, Mulder H. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 1995;99:235-42.
11. 11. Sambrook M, Birmingham J, Kelly P, Kempler S, Nguyen T, Stat M, et al. Prevention of corticosteroid osteoporosis a comparison of calcium, calcitriol, and calcitonin. NEJM 1993;328:1747-52.
12. 12. Mulder H, Struys A. Intermittent cyclical etidronate in the prevention of steroid-induced osteoporosis. Br J Rheumatol 1994;33:348-50.
13. 13. Adachi J, Cranney A, Goldsmith C, et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol 1994;21:1922-6.
14. 14. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. NEJM 1997;337:382-7.
15. 15. Jergas M, Genant HK, Nevitt M. Standardised visual assessment of osteoporotic vertebral deformities. In: Genant HK, et al. eds. Vertebral fracture in osteoporosis. Radiology Research and Education Foundation, University of California, 1995:149-161.
16. 16. Lukert BP, Raiz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.